Johnson & Johnson

By default your notes are visible only to you.

149.0

52-week range

251.7

225.33

Your model inputs

Required return / cost of capital

FCFF terminal growth rate

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per share

3.2 %

Dividend Yield TTM

2.3 %

Market cap $

$ 542,419

Price / Earnings TTM

P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per share

Price / Book TTM

6.8

PEG TTM

Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rate

0.3

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

50.1 %

47 %

135.7 %

Free cash flow per share growth

(0.7) %

7.3 %

44.2 %

Earnings per share growth

90.5 %

100.2 %

101.3 %

Founded: 1,886

Employees: 138,100

Business Summary:Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Fair Value Reference Estimate